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Very long chain fatty acids (VLCFA), either free or as components of glycerolipids and sphingolipids, are present 
in many organs. Elongation of very long chain fatty acids-4 (ELOVL4) belongs to a family of 6 members of 
putative fatty acid elongases that are involved in the formation of VLCFA. Mutations in ELOVL4 were found to 
be responsible for an autosomal dominant form of Stargardt’s-like macular dystrophy (STGD3) in human. We 
have previously disrupted the mouse Elovl4 gene, and found that Elovl4+/- mice were developmentally normal, 
suggesting that haploinsufficiency of ELOVL4 is not a cause for the juvenile retinal degeneration in STGD3 
patients. However, Elovl4-/- mice died within several hours of birth for unknown reason(s). To study functions of 
ELOVL4 further, we have explored the causes for the postnatal lethality in Elovl4-/- mice. Our data indicated that 
the mutant mice exhibited reduced thickness of the dermis, delayed differentiation of keratinocytes, and 
abnormal structure of the stratum corneum. We showed that all Elovl4-/- mice exhibited defective skin water 
permeability barrier function, leading to the early postnatal death. We further showed that the absence of 
ELOVL4 results in depletion in the epidermis of ceramides with ω-hydroxy very long chain fatty acids (≥C28) and 
accumulation of ceramides with non ω-hydroxy fatty acids of C26, implicating C26 fatty acids as possible 
substrates of ELOVL4. These data demonstrate that ELOVL4 is required for VLCFA synthesis that is essential for 
water permeability barrier function of skin. 
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1.  Introduction 
Mammalian skin consists of a dermis and an 
epidermis. Keratinocytes in the basal layer of the 
epidermis are epidermal precursor cells that undergo 
both continuous proliferation to maintain their 
population and differentiation when they migrate in 
the direction of the skin surface [1,2]. The sequential 
differentiation of keratinocytes results in the formation 
of several anatomically distinct layers, including the 
stratum basale, the stratum spinosum, the stratum 
granulosum and the stratum corneum [3]. The stratum 
corneum (SC) is the outermost layer of the epidermis 
and serves as a barrier for transepidermal water loss 
that is essential to prevent dehydration. Ceramides, a 
class of sphingolipids with a sphingoid base in amide 
linkage with a fatty acid, are major and essential 
components of the water barrier in epidermis [3-6]. A 
substantial portion of epidermal ceramides contain 
ω-hydroxy long chain fatty acids (C>28), which can be 
in the form of linoleic acid acyl esters or bound to 
protein [7,8].  
Elongation of very long chain fatty acids-4 
(ELOVL4) belongs to a family that consists at least 6 
putative fatty acid elongases in mouse and human [9]. 
The ELOVL4 gene encodes a putative 314 aa protein 
that is highly conserved through evolution [10,11]. 
ELOVL4 is expressed in brain, retina, skin, lens, and 
testis in mice [12]. Mutational analysis of the ELOVL4 
gene in patients suffering Stargardt’s macular 
dystrophy 3 (STGD3) detected a 5 bp deletion, which 
results in a frame-shift that truncates 51 aa from the 
C-terminal end of ELOVL4 [13-15]. STGD3 is an 
autosomal dominant juvenile retinal disease 
characterized by progressive accumulation of 
lipofuscin, atrophy of the retinal pigment epithelium, 
and degeneration of macular photoreceptors [13,16,17]. 
Consistent with a view that the 5-bp deletion of the 
ELOVL4 gene is responsible for the STGD3, mice either 
over expressing a 5-bp ELOVL4 deletion transgene in 
retina driven by a human photoreceptor-specific 
promoter of the gene encoding interphotoreceptor 
retinoid-binding protein (IRBP-ELOVL4) ([18], Li and 
Deng unpublished data), or carrying a targeted 5-bp 
ELOVL4 deletion in heterozygous state (Elovl4+/del) [19] Int. J. Biol. Sci. 2007, 3 
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recapitulate major features of the retinal pathogenesis 
in STGD3 patients.  
To study function of ELOVL4, we have generated 
a candidate null mutation by inserting of a neo cassette 
[20]  into the exon 2 of the Elovl4  locus [21]. Our 
analysis indicated that mice heterozygous for the 
mutation (Elovl4+/-) were developmentally normal 
and did not exhibit apparent photoreceptor 
degeneration up to 11 months of age [21]. Because the 
Elovl4+/del mice and IRBP-ELOVL4  transgenic mice 
develop early onset of photoreceptor ultrastructural 
abnormalities, while the Elovl4+/- mice are normal, this 
observation suggests that a dominant negative effect, 
rather than haploinsufficiency, is the primary 
mechanism of juvenile retinal degeneration in STGF3 
patients.  
Notably, we also found that Elovl4-/- mice, while 
exhibiting normal retinal development, died several 
hours after birth due to unknown causes [21]. These 
data suggest that ELOVL4 is indispensable for the 
early stages of postnatal survival. Here we have 
further analyzed Elovl4-/- mice and found that they all 
displayed profound skin atrophy and impaired water 
insulation function. The mutant mice also lacked 
ceramides with ω-hydroxy very long chain fatty acids 
(>C28) indicating that ELOVL4 is critical for the 
formation of epidermal-specific sphingolipids with 
essential permeability barrier function. 
2.  Materials and Methods 
Mice 
Mice carrying a heterozygous mutation of Elovl4 
(Elovl4+/-) were genotyped as described [21]. The 
Elovl4+/- mice were interbred to generate Elovl4-/- mice, 
which were collected at birth and were subjected to 
various analyses described in the text. All the mice 
were in a mix background of 129SVEV and Black Swiss 
at a roughly 1:1 ratio. Animal care is in accordance 
with guidelines of animal user and care committee of 
NIDDK.  
Histology and immunohistochemical staining  
For histology, tissues were fixed in 10% formalin, 
blocked in paraffin, sectioned, stained with 
hematoxylin and eosin, and examined by light 
microscopy. Detection of primary antibodies was 
performed using the ZYMED HistomouseTM SP Kit 
according to the manufacturer’s instructions. 
Antibodies for involucrin, loricrin, filaggrin, K14, and 
K6 were purchased from Covance Inc.  
Skin permeability assay 
The unfixed the newborn pups were incubated 
for 5 min in methanol, rinsed with PBS, and followed 
by incubation in 0.5% hematoxylin for 30 min. 
Electronmicroscopy 
Pancreas tissue was fixed in 2% glutaraldehyde in 
0.1 M cacodylate buffer, pH 7.4, overnight at 4oC. The 
tissue was washed with cacodylate buffer and 
postfixed with 1% OsO4 tetroxide for two hours. Tissue 
was washed again with 0.1 M cacodylate buffer, 
serially dehydrated in ethanol and propylene oxide 
and embedded in Eponate 12 resin (Ted Pella, Redding, 
CA, USA). Thin sections, approx. 80 nm, were obtained 
by utilizing the Leica ultarcut-UCT ultramicrotome 
(Leica, Deerfield, Ill., USA) and placed onto 300 mesh 
copper grids and stained with saturated uranyl acetate 
in 50% methanol and then with lead citrate. The grids 
were viewed in the Philips 410 electron microscope 
(FEI, Hillsboro, OR, USA) at 80 kV and images were 
recorded on Kodak S0-163 film. 
Analysis of ceramids in epidermis by 
nanoESI-MS/MS 
Sphingolipid extraction and mass spectrometric 
analysis were performed according to Jennemann et al. 
[22]. In brief, skins were trypsinized over night at 4 °C 
to separate epidermis from dermis. Lyophilized tissue 
was extracted once with chloroform/methanol/water 
in a ratio of 30:60:8 by vol. and twice in a ratio of 
10:10:1 by vol., each for 15 at 50 °C in an ultra-sound 
bath. Combined extracts were desalted using reversed 
phase RP-18 columns. In order to cleave esterified 
sphingolipids, aliquots of these free extractable lipids 
were further saponified with 0.1 M KOH in methanol 
for 2 hours at 50 °C, neutralized and desalted using 
reversed phase RP-18 columns. In order to remove 
residual free lipids, the remaining protein pellets were 
treated 3 times with methanol at RT for 10 min and 2 
times with 95 % methanol at 60 °C. From these 
“washed” protein pellets, protein bound lipids were 
released with 1 M KOH in 95 % methanol at 60 °C for 2 
hours. Supernatant was neutralized with 1 M acetic 
acid, dried and desalted using reversed phase RP-18 
columns. Quantification of sphingolipids was 
performed by nanoESI-MS/MS using a precursor ion 
scan of m/z +264 for ceramide- and GlcCer-detection 
(collision energy: 50 eV) as described by Sandhoff et al. 
2002 [23] with slight modifications: Starting with 35 V 
at m/z = 500, the cone voltage was increased in a linear 
way up to 65 V at m/z = 1300 during the measurement. 
For quantification of ceramides (Cers) and GlcCers the 
following internal standards were added in an 
equimolar ratio to the samples Cer(d18:1,14:0), 
Cer(d18:1,19:0), Cer(d18:1,25:0), Cer(d18:1,31:0), and 
Cer(t18:0,31:0), and 
GlcCer(d18:1,14:0),GlcCer(d18:1,19:0), 
GlcCer(d18:1,25:0), and Cer(d18:1,31:0). 
3.  Results 
ELOVL4 deficient mice showed defective epidermis 
permeability barrier function 
To investigate the causes that are responsible for 
early postnatal lethality of the Elovl4-/- mice, we 
carefully monitored the newborn Elovl4-/- mice and 
found that all mutant mice were alive at the birth and 
presented a Mendelian ratio (Elovl4-/-: 31, Elovl4+/+: 58, 
Elovl4-/-: 32). These mice were initially slightly smaller 
than wild type controls (Fig. 1A), and became more 
obviously smaller prior to their death within 5 hours 
after birth. Meanwhile, the skin Elovl4-/- mice 
appeared dark/purple in color and less smooth than Int. J. Biol. Sci. 2007, 3 
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the skin of control (Elovl4 wild type and heterozygous) 
mice (Fig. 1A). These phenotypes became 
progressively more severe and all mutant mice 
exhibited remarkable wrinkled skin a few hours after 
birth (Fig. 1B). The skin serves as a permeability barrier 
for body water loss. Therefore, we checked speed of 
water loss during a given period of time by measuring 
body weight every 30 min up to 3 and half hours. The 
Elovl4-/- mice lost body water at a rapid rate (~12% in 
210 min), in contrast to all control mice, which 
maintained consistent body weight during the same 
p e r i o d  o f  t i m e ,  s u g g e s t i n g  the wild type skin could 
prevent water evaporation, but the mutant skin could 
not (Fig. 1C).  
Next, we performed a skin permeability assay by 
soaking newborn mice into 0.5% hematoxilin for 30 
minutes. We found that the Elovl4-/- mice were quickly 
stained by hematoxilin (Fig. 1D), while the dye could 
not penetrate the skin of control mice (Fig. 1E). These 
data indicate that ELOVL4 deficiency impaired the 
permeability barrier function of the 
skin, leading to the early postnatal 
lethal of the Elovl4-/- mice. Consistent 
with this, we have supplied body lotion, 
which reduces water loss from the skin, 
to 3 mutant mice and found that they 
all survived beyond 24 hours, although 
died before 36 hours after birth.  
Figure 1. Defective skin water barrier 
function in the Elovl4-/- mice. (A, B) 
Appearance of Elovl4-/- (left) and control 
mice ∼2 hours (A) and ∼4 hours (B) after 
birth. (C) The speed of water loss. Newborn 
mice were weighted at the different time 
points as indicated. (D, E) Skin permeability 
assay. The Elovl4-/- mice (D) were strongly 
stained by 0.5% hematoxylin 5 minutes 
after staining, but heterozygous mice and 
wild type mice (E) were resistant to the 
staining.  
 
ELOVL4 deficient mice showed 
impaired epidermis keratinocyte 
differentiation 
Next, we performed histological 
analysis of the skin of newborn mice. In 
wild type mice, the SC is a multi-layer, 
loosely packed structure that is in the 
outermost of the skin (Fig. 2A-C). 
However, in the mutant mice the SC 
appeared thinner than control SC, and 
presented as split layers with varying 
severity in all mutant pups examined 
(n>10) (Fig. 2D-F, G-I), instead as a 
cohesive multi-layer structure in 
control mice (Fig. 2C). The thickness of 
stratum basal (Bl), spinosum (Sp), and granulosum (Gr) 
layers were increased (Fig. 2C, F). In addition, 
thickness of the dermis of the Elovl4-/- mice was 
reduced than that of the control mice (Fig. 2B, E, H).  
To further characterize the abnormalities of 
mutant skin, we performed immunohistochemical 
staining using various lineage markers for the 
epidermis. The K14 marked the basal layer of 
keratinocytes, which are arranged as a one- or two-cell 
layer in the control mice (Fig. 3A), whereas in the 
Elovl4-/- mice, K14 expression domain was expanded 
to multi-cell layer (Fig. 3B). Keratinocytes located in 
the basal layer are precursor stem cells for the 
epidermis. These cells maintain their population 
through proliferation, and also undergo continuous 
differentiation to generate cells for other layers above. 
The expansion of basal layer keratinocytes in mutant 
epidermis could be caused by increased cell 
proliferation, and/or reduced differentiation. Using 
BrdU incorporation assay, we did not detect an 
obvious increase of BrdU positive cells in the basal 
layer of the mutant epidermis relative to control 
epidermis (Fig. 3C, D). In the control basal layer, BrdU 
positive cells maintained, in most case, within the 
single cell layer (arrows, Fig. 3C). In contrast, the BrdU 
labeled mutant cells appeared in different layers (Fig. 
3 D ) ,  w h i c h  i s  c o r r e s p o n d i n g  t o  t h e  e x p a n d e d  K 1 4  
expression domain (Fig. 3B). In addition, the basal 
layer in the mutant epidermis was positively stained Int. J. Biol. Sci. 2007, 3 
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by an antibody against K6, a marker for abnormal 
differentiation (Fig. 3F), while control epidermis was 
negative (Fig. 3E). These data indicate that the absence 
of ELOVL4 caused abnormal keratinocyte 
differentiation.  
The SC is formed by the terminal differentiation 
of keratinocytes. During this process, cells sequentially 
incorporate precursor proteins, involucrin and loricrin, 
while filaggrin promotes aggregation and packing of 
keratin filaments to form a dense cell matrix. Our data 
indicated that the expression of these proteins was on 
primarily in the SC and upper granular in control mice 
(Fig. 3G, I, K). However, in the ELOVL4 knockout mice, 
these proteins remained in the spinous layer, and the 
granular layer, in addition to the SC layer (Fig. 3H, J, L). 
These data indicated that ELOVL4 deficiency 
interfered with the terminal differentiation of 
keratinocytes, leading to the impaired formation of the 
SC.  
 
Figure 2. Abnormal skin formation of the Elovl4-/- mice revealed by H&E staining. Histology of the skin from a wild type 
(A-C) and two Elovl4-/- (D-I) newborn mice. Arrows in (A, D, G) point to the SC. Bars in (B, E, H) indicate the thickness of 
dermis. Arrows in (C, F, I) point to basal layer of the epidermis. Hf: hair follicle, Sc: stratum corneum, Gr: stratum granulosum, 
Sp: stratum spinosum, Bl: stratum basale. Original magnification of (A, D, G) is 100X, (B, E, H) is 200X, and (C, F, I) is 
400X. 
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Figure 3. Delayed differentiation of keratinocytes in the skin of the Elovl4-/- mice. Samples shown in (A, C, E, G, I, K) are 
control and in (B, D, F, H, J, L) are mutant. Antibodies used were as indicated. Arrows in (C, D) point to BrdU positive cells 
in the basal layer of control (C) and mutant (D) epidermis. 
 
 
We have noticed that, unlike the control pups, the 
mutant animals showed very little movement and had 
no desire to find the nipple and to suck milk from their 
mothers. Initially, we had considered whether 
starvation could also serve as a cause for the lethality. 
However, after feeding 4 mutant pups with milk 
purchased from supermarket through gavaging, we 
found it did not extend the time of survival of the 
mutant mice. We have also checked many other organs 
of mutant mice, including the brain, esophagus, heart, 
liver, lung, intestine, pancreas, spleen, and stomach, 
and did not find a consistent defect that could be 
responsible for the early postnatal lethality (not 
shown). 
ELOVL4 deficiency resulted in abnormal 
ultrastructure in the SC  
Next, we investigated if there were any 
ultrastructural abnormalities in the mutant epidermis 
using electron microscopy. The wild type SC appeared 
as a loosely packed basket weaved structure (Fig. 4A). 
In contrast, the SC of the Elovl4-/- mice was much more 
compact than control SC (Fig 4B). Our histological 
analysis performed earlier revealed that the SC in the 
Elovl4-/- mice was often presented as split sub-layers 
from the skin (Fig. 2D, G). Altogether, these data 
suggest that although the mutant SC is more compact, 
sub-layers within the SC fail to adhere, and, in most 
cases, peel off from the skin. No difference in the 
lamellar membrane at the stratum spinosum and the 
stratum granulosum interface was found between 
mutant mice and wild type (Fig. 4C, D). The basement 
membrane in Elovl4-/- mice had fewer 
hemidesmosomes, the attachment sites of epithelial 
cells to basal lamina, with shortened or missing 
tonofilaments (arrowheads, Fig. 4E, F). Collagenous 
fibrils were also sparse and shorter in the mutant mice 
than controls (arrows, Fig. 4E, F). 
  Int. J. Biol. Sci. 2007, 3 
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Figure 4. Ultrastructural abnormalities in the skin of the Elovl4-/- mice. (A, B) Electron micrographs of the wild type (A), and 
the mutant (B) stratum corneum. The SC in the mutant is more compacted than the control, which has space between each 
sub-layer. (C, D) Enlarged images of the boxed areas in (A and B). Arrows point to the lamellar membrane between the 
stratum spinosum and the stratum granulosum. (E, F) Basement membrane in Elovl4-/- mice (F) had fewer hemidesmosomes 
with shortened or missing tonofilaments (arrows) than control mice (E). Collagenous fibrils in mutant mice were shorter and 
sparse than controls (arrowheads). Magnification: A, B: X23,457; C, D: X51,605; and E, F: X29,280. 
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Figure 5. Expression of ceramides with different length fatty acids in the epidermis of the Elovl4-/- mice. Total epidermal 
ceramides from Elovl4-/- (null), heterozygous (ht) and wild-type (wt) mice with different fatty acid chain lengths (C16-25, 
C26, C28, C30-36) were quantified by nanoESI-MS/MS. The results are expressed as percentage of total ceramides.  
 
Figure 6. Expression of ceramides with ω- hydroxy fatty acids in in the epidermis of the Elovl4-/- mice. The following 
ceramide species were quantified from epidermis of Elovl4-/-  (null),  heterozygous (ht) and wild-type (wt) mice by 
nanoESI-MS/MS: ceramides containing ω-hydroxy fatty acids (OS), ceramides containing ω-hydroxy fatty acids esterified to 
linoleic acid (EOS), ceramides containing ω-hydroxy fatty acids bound to protein (POS), ceramides containing non-hydroxy 
fatty acids (NS) and ceramides containing α-hydroxy fatty acids (AS). The results are expressed as the percentage of total 
ceramides. 
 
Depletion of ceramides with ω-hydroxy very long 
fatty acids in the ELOVL4 deficient mice 
Ceramides containing ω-hydroxy very long chain 
fatty acids are essential components of the epidermal 
permeability barrier. These can be expressed as free 
(OS), linoleic acid esterified (EOS) and in protein 
bound (POS) forms. In the Elovl4-/- epidermis, mass 
spectrometric analysis revealed that ceramides 
containing fatty acids longer than C28 (C30-36) were 
absent, and those with C28 fatty acids were 
substantially reduced compared with controls (Fig. 5). 
These included ω-hydroxyceramides (OS, POS and 
EOS) that were found in wild-type and heterozygote 
epidermis with fatty acid lengths equal or longer than 
C28 (Fig. 6). In contrast, the Elovl4-/-  epidermis 
contained predominantly non-hydroxy (NS)-, 
α-hydroxy (AS)-ceramides with C26 as longest fatty 
acid (Fig. 5 and 6). Interestingly, the amount of these 
ceramides with C26 fatty acids was nearly double the 
amount in Elovl4-/- mice compared with the wild-type 
and heterozygous mice (Fig. 5), while the amounts of 
ceramides with C16-25 fatty acids were similar in the Int. J. Biol. Sci. 2007, 3 
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three genotypes, indicating that the absence of 
ELOVL4 caused an accumulation of NS- and 
AS-ceramides with C26 fatty acids. 
4.  Discussion 
EVOVL4 is highly expressed in the human retina 
and was initially discovered as the causal gene of 
STGD3 [13]. Consistently, mutant mice carrying the 
dominant negative form of human ELOVL4 gene that was 
either introduced through a knock-in approach (Elovl4+/del), 
or transgenic approach (IRBP-ELOVL4) developed early 
onset of progressive photoreceptor degeneration 
([18,19], Li and Deng unpublished data). In contrast, 
mice heterozygous for a conventional knockout of 
ELOVL4 developed normally and exhibited no 
symptoms mimicking human STGD3 [21]. 
Furthermore,  Elovl4-/- mice died unexpected shortly 
after birth, suggesting that ELOVL4 may play 
additional functions in other organs/tissues that are 
critical for early postnatal survival. In addition to the 
eye, ELOVL4 is also presented at high levels in the skin 
and brain [12]. Our analysis of Elovl4-/- mice revealing 
the abnormal differentiation of keratinocytes, and 
malformation of the SC of the skin indicate that 
ELOVL4 indeed have critical functions in other organs 
in addition to the eye. 
The SC of the skin serves as a permeability barrier 
for protecting the internal milieu against the external 
environment. Previous investigations indicated that 
mutant mice with malformation of the SC died of 
dehydration shortly after birth [24-26], establishing 
that the water barrier function of the SC is critical for 
postnatal survival. Our data revealed that the SC of 
Elovl4-/-mice failed to protect against body water 
evaporation and dye penetration. The mutant SC is 
thinner and more compact than that of control mice. It 
also displayed ultrastructural abnormalities and 
detached from the mutant mice. These observations 
are consistent with a view that that the Elovl4-/- mice 
died of dehydration.  
Despite the high level of ELOVL4 expression in 
the brain [12], our examination failed to reveal an 
obvious histological/morphological difference 
between mutant and control mice. Of note, we found 
that the Elovl4-/- m i c e  s h o w e d  n o  d e s i r e  t o  f i n d  t h e  
nipple and to suck milk of their mothers. Consequently, 
all the mutant mice did not drink any milk until their 
death. Our study ruled out that starvation could be a 
cause for the lethality, as feeding of mutant mice with 
milk does not extend their life beyond 6 hours. 
Meanwhile, the Elovl4-/- mice also had very little body 
movement. We suspect these phenotypes reflect a 
neurological behavior abnormality due to the absence 
of ELOVL4 in the brain. Studies using lineage and 
molecular markers should be performed in the future 
to detect alterations in cellular and molecular levels to 
provide an explanation for these abnormalities. 
A key finding to explain the early death of the 
Elovl4-/-  mice was the absence of ceramides with 
ω-hydroxy very long chain fatty acids in the epidermis 
of the mutant mice. This finding uncovered an 
indispensable role for ELOVL4 in the formation of the 
very long chain fatty acids that serve as constituents of 
sphingolipids in the epidermal barrier. The lipid 
barrier that is found on the surface of corneocytes in 
stratum corneum provides epidermal permeability 
barrier function, and is required for terrestrial life 
[3,24-26]. The lipid barrier expresses ceramides as 
major components, with ceramides containing 
ω-hydroxyl very long chain fatty acids comprising a 
significant fraction of epidermal ceramides. Together 
with a deficiency of ceramides containing fatty acids 
longer than C28, was the relative accumulation of 
ceramides containing C26 fatty acids. These results 
suggest that C26 fatty acids are substrates for ELOVL4 
and that ω-hydroxylation probably occurs on fatty 
acids of chain length C28 or longer. It is plausible that 
the absence of ≥C28 fatty acids in ELOVL4 null 
epidermis blocked the synthesis of ceramides with 
ω-hydroxy fatty acids and, consequently, and their 
linkage to linoleic acid and protein. 
  So far six members of ELOVL (ELOVL1-6) have 
been identified and these enzymes exhibit spatially 
and temporally specific expression [9]. It was reported 
that  Elovl3 gene expression in mouse skin was 
restricted to the sebaceous glands and the epithelial 
cells of the hair follicles [27]. The disruption of the 
Elovl3 gene in mouse resulted in a sparse hair coat, the 
hyperplasia of the sebaceous glands, and the increased 
level of eicosenoic acid (20:1) in hair lipids [27]. The 
result showed that ELOVL3 participates in the 
formation of neutral  lipids bound with fatty acids 
longer than C20 that are necessary for skin function. 
These studies revealed that ELOVL3 and ELOVL4 
have distinct functions in the skin. 
While our work is completed, a study using the 
skin of Elovl4del/del mice was published online [28]. In 
that study, Basireddy et al. revealed a similar defect in 
skin permeability due to the depletion of fatty acids 
≥C28 in the mutant SC. However, immunofluorescence 
using epidermal markers did not detect any obvious 
differences between the Elovl4del/del and control mice 
[28]. A plausible explanation is that the Elovl4del/del mice 
still express the mutant form of ELOVL4 that is 51aa 
shorter than the full-length protein (314aa). The 
dominant-negative nature of this mutant form of 
ELOVL4 might be a cause for the observed differences 
between the Elovl4del/del and Elovl4-/- mice. This issue 
deserves further investigations in the future.  
Similar phenotypes were found in mice carrying 
either a null mutation of ELOVL4 (Elovl4-/-) or a 
truncation of ELOVL4 at 270aa (Elovl4270X/270X) [29], 
which appears in the same issue of the International 
Journal of Biological Sciences. 
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